IgA 肾病的免疫抑制治疗：我们有多大把握？
Immunosuppression in IgA nephropathy: how certain are we?
机构信息
Division of Nephrology and Clinical Immunology, RWTH University of Aachen, Aachen, Germany.
Division of Nephrology and Clinical Immunology, RWTH University of Aachen, Aachen, Germany.
出版信息
Kidney Int. 2016 Jan;89(1):9-11. doi: 10.1016/j.kint.2015.11.013.
PMID:26759037
Abstract
The optimal role of immunosuppressive therapy in the treatment of IgA nephropathy is controversial. Results of a recently completed randomized controlled trial provide strong support for comprehensive supportive care rather than immunosuppressive therapy in patients at high risk for progression.
摘要
免疫抑制疗法在 IgA 肾病治疗中的最佳作用存在争议。最近完成的一项随机对照试验的结果为高危进展患者提供了强有力的支持，即全面支持性治疗而非免疫抑制疗法。
Zotero 插件